Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.

Fowke JH, Shu XO, Dai Q, Jin F, Cai Q, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1308-15.

2.

A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.

Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1462-7.

3.

Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.

Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1290-5.

4.
5.

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.

PMID:
16807674
6.

Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.

Cui Y, Shu XO, Cai Q, Jin F, Cheng JR, Cai H, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1096-101.

7.

Population-based case-control study of CYP11A gene polymorphism and breast cancer risk.

Zheng W, Gao YT, Shu XO, Wen W, Cai Q, Dai Q, Smith JR.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):709-14.

8.
9.

Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.

Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.

Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):413-9.

10.

Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.

Brinton LA, Gammon MD, Malone KE, Schoenberg JB, Daling JR, Coates RJ.

Contraception. 1997 Apr;55(4):197-203.

PMID:
9179450
11.

Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.

Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P.

Lung Cancer. 2001 Aug-Sep;33(2-3):133-41.

PMID:
11551408
12.

The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.

Hirose K, Matsuo K, Toyama T, Iwata H, Hamajima N, Tajima K.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1407-11.

13.

Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.

Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):89-94.

14.

Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.

Fleming RA, Drees J, Loggie BW, Russell GB, Geisinger KR, Morris RT, Sachs D, McQuellon RP.

Pharmacogenetics. 2002 Jan;12(1):31-7.

PMID:
11773862
15.

Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking.

Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH.

Pharmacogenetics. 1995 Aug;5(4):199-206.

PMID:
8528266
16.

NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer.

Harth V, Donat S, Ko Y, Abel J, Vetter H, Brüning T.

Arch Toxicol. 2000 Jan;73(10-11):528-31.

PMID:
10663383
17.

Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.

Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):583-91.

18.

Association of cyclin D1 genotype with breast cancer risk and survival.

Shu XO, Moore DB, Cai Q, Cheng J, Wen W, Pierce L, Cai H, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):91-7.

19.

Use of oral contraceptives, alcohol, and risk for invasive breast cancer.

Dumeaux V, Lund E, Hjartåker A.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1302-7.

20.

Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):127-35.

Supplemental Content

Support Center